Attorney General Misses Deadline to Streamline Research on Psychedelics
The Department of Justice failed to meet a January 16 deadline to publish new rules simplifying Schedule I research.
Read MoreLegalization updates, FDA decisions, state laws, decriminalization, and regulatory news.
The Department of Justice failed to meet a January 16 deadline to publish new rules simplifying Schedule I research.
Read More
The FDA's decision could deliver the first psychedelic medicine approved by the FDA as soon as this summer.
Read More
Psychedelic therapy is now legal in Colorado. Here's an overview of what this means for those looking for treatment.
Read More
Connecticut is widening access to a medical psychedelic therapy program at a moment when public interest has clearly outpaced availability.
Read More
Reunion Neuroscience announced that its drug luvesilocin received Breakthrough Therapy Designation for the treatment of postpartum depression.
Read More
Trump’s executive order on psychedelics pushed a once fringe issue into the center of health policy. The coverage shows a
Read More
Once a fringe topic whispered about in small circles, psychedelics are way ahead of cannabis when it comes to reform.
Read More
The Texas Medical Board rewrote its proposed ketamine rules. The July 10 version is out. Here's what Texas clinics should
Read More
A bipartisan group of military veterans serving in the U.S. Senate introduced legislation that could fundamentally change how the VA
Read More
Here's a timeline of Washington's evolving view on psychedelics. From LSD research to the War on Drugs to today’s push
Read More